Erysipelothrix rhusiopathiae (E. rhusiopathiae) is an important pathogenic microorganism affecting swine industry. Here, we report the finished annotated genome sequence of E. rhusiopathiae GXBY-1, isolated from acute swine erysipelas in Binyang County, Guangxi, China. The GXBY-1 strain, which exhibits high pathogenicity for swine, contains 1,876,490 bp with G + C content of 36.50%, and contains 1734 protein-coding genes, 57 tRNAs and 27 rRNAs. The nucleotide sequence of this genome was deposited into GenBank under the accession CP014861.
A salen nickel complex has been prepared in good yield with ethylenediamine, salicylaldehyde, and NiCl2·6H2O as raw materials. The structure of the complex was characterized by FTIR, 1H NMR, UV, and ESI-MS. Upon activation with methylaluminoxane (MAO), the precatalyst showed high activity for ethylene oligomerization. To reduce the simultaneous production of insoluble polymers during the nickel-catalyzed ethylene oligomerization, a series of phenolic compounds were introduced as modifiers for the production of linear α-olefins. The researched result showed that the phenolic compounds have a significant impact on the selectivity of oligomers and the concentration of polymers. With the increase of phenolic compounds, the content of polymers decreased and the distribution of oligomers gradually shifted toward lighter olefins. The sterically hindered 4-tert-butyphenol proved to be an especially efficient polymer-retarding modifier among the studied phenolic compounds in this work. Furthermore, the retarding effect of phenolic compounds toward insoluble polymers may be mainly related to their interaction with MAO, giving rise to larger MAO aggregates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.